anonymous
Guest
anonymous
Guest
I may be interested in the LTC Sales Specialist position but my main reservation is around the controversy surrounding Nuplazid and the deaths in Parkinson's patients. Why would this perception change for DRP patients and would this make it a difficult sell? Thanks in advance for intelligent and candid replies from existing LTC reps.